Brief: Compugroup Medical Sees FY Adjusted EBITDA Between EUR 220-250 Million

CompuGroup Medical SE & Co KgaA

07/11/2024 06:39

Nov 7 (Reuters) - COMPUGROUP MEDICAL SE & CO KGAA
 COP1n.DE :
    * CGM DRIVES INNOVATION IN THE THIRD QUARTER WHILE RECORDING
EARNINGS DECLINE WITH ALMOST STABLE REVENUES
    * REVENUES OF EUR 283.4 MILLION IN Q3
    * Q3 RECURRING REVENUES INCREASED BY 6 PERCENT TO EUR 213.5
MILLION (PY: EUR 202.2 MILLION)
    * ADJUSTED EBITDA IS EXPECTED TO BE IN A RANGE BETWEEN EUR
220
MILLION AND EUR 250 MILLION FOR FY
    * Q3 ADJUSTED EBITDA DECLINED BY 12 PERCENT TO EUR 54.9
MILLION
(PY: EUR 62.2 MILLION)
    * Q3 EBITDA MARGIN STOOD AT 19 PERCENT (PY: 22 PERCENT)
    * ADJUSTED EPS AT EUR 0.35 IN Q3 (PY: EUR 0.43)
    * FY ORGANIC REVENUE DEVELOPMENT SEEN IN RANGE BETWEEN -2
PERCENT
AND 0 PERCENT YOY

Source text:  ID:nEQ1xRHJqa 
Further company coverage:  COP1n.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))